Findings from the SUMMIT, Altshock-2, and FAIR-HF2 trials were presented at the American College of Cardiology 2025 Annual ...

Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...

The full results of the phase III REVERSE-IT trial continue to show that ticagrelor (Brilinta)-reversing therapy bentracimab ...

“Stabilization prior to and during transport is critical, and the AC3 Range™ Intra-Aortic Balloon Pump helps address ... interventional cardiology and radiology, surgical, vascular access ...

“Stabilization prior to and during transport is critical, and the AC3 Range™ Intra-Aortic Balloon Pump helps address this need with ... emergency medicine, interventional cardiology and radiology, ...

"Stabilization prior to and during transport is critical, and the AC3 Range Intra-Aortic Balloon Pump helps address this need with ... emergency medicine, interventional cardiology and radiology, ...

"Results from the early use of an intra-aortic balloon pump were comparable ... In 2023, European Society of Cardiology guidelines recommended against routine IABP use in patients with cardiogenic ...

This may ultimately cause the pump to malfunction ... at the Department of Cardiology and director of structural heart interventions at NHCS, said: “While balloon and stent techniques are ...

It will be presented at the upcoming American College of Cardiology (ACC ... Results of trials of intra-aortic balloon pumps and extracorporeal life support have generally been negative.